Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 14 |
GO:0110165 | cellular anatomical entity | 1 | 14 |
GO:0005783 | endoplasmic reticulum | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: E9B1X8
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 14 |
GO:0006643 | membrane lipid metabolic process | 4 | 14 |
GO:0006665 | sphingolipid metabolic process | 4 | 14 |
GO:0006672 | ceramide metabolic process | 4 | 14 |
GO:0006807 | nitrogen compound metabolic process | 2 | 14 |
GO:0008152 | metabolic process | 1 | 14 |
GO:0008610 | lipid biosynthetic process | 4 | 14 |
GO:0009058 | biosynthetic process | 2 | 14 |
GO:0009987 | cellular process | 1 | 14 |
GO:0030148 | sphingolipid biosynthetic process | 5 | 14 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 14 |
GO:0043603 | amide metabolic process | 3 | 14 |
GO:0043604 | amide biosynthetic process | 4 | 14 |
GO:0044237 | cellular metabolic process | 2 | 14 |
GO:0044238 | primary metabolic process | 2 | 14 |
GO:0044249 | cellular biosynthetic process | 3 | 14 |
GO:0044255 | cellular lipid metabolic process | 3 | 14 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 14 |
GO:0046467 | membrane lipid biosynthetic process | 4 | 14 |
GO:0046513 | ceramide biosynthetic process | 5 | 14 |
GO:0071704 | organic substance metabolic process | 2 | 14 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 14 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 14 |
GO:1901576 | organic substance biosynthetic process | 3 | 14 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 14 |
GO:0016410 | N-acyltransferase activity | 5 | 14 |
GO:0016740 | transferase activity | 2 | 14 |
GO:0016746 | acyltransferase activity | 3 | 14 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 14 |
GO:0050291 | sphingosine N-acyltransferase activity | 6 | 14 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 246 | 252 | PF00089 | 0.533 |
CLV_NRD_NRD_1 | 127 | 129 | PF00675 | 0.384 |
CLV_NRD_NRD_1 | 137 | 139 | PF00675 | 0.322 |
CLV_NRD_NRD_1 | 297 | 299 | PF00675 | 0.337 |
CLV_NRD_NRD_1 | 35 | 37 | PF00675 | 0.720 |
CLV_NRD_NRD_1 | 452 | 454 | PF00675 | 0.565 |
CLV_NRD_NRD_1 | 457 | 459 | PF00675 | 0.560 |
CLV_PCSK_KEX2_1 | 127 | 129 | PF00082 | 0.388 |
CLV_PCSK_KEX2_1 | 221 | 223 | PF00082 | 0.238 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.720 |
CLV_PCSK_KEX2_1 | 452 | 454 | PF00082 | 0.566 |
CLV_PCSK_KEX2_1 | 457 | 459 | PF00082 | 0.562 |
CLV_PCSK_PC1ET2_1 | 221 | 223 | PF00082 | 0.256 |
CLV_PCSK_PC1ET2_1 | 457 | 459 | PF00082 | 0.517 |
CLV_PCSK_PC7_1 | 453 | 459 | PF00082 | 0.517 |
CLV_PCSK_SKI1_1 | 140 | 144 | PF00082 | 0.350 |
CLV_PCSK_SKI1_1 | 218 | 222 | PF00082 | 0.312 |
CLV_PCSK_SKI1_1 | 299 | 303 | PF00082 | 0.269 |
CLV_PCSK_SKI1_1 | 407 | 411 | PF00082 | 0.489 |
CLV_PCSK_SKI1_1 | 427 | 431 | PF00082 | 0.366 |
CLV_Separin_Metazoa | 8 | 12 | PF03568 | 0.242 |
DOC_ANK_TNKS_1 | 10 | 17 | PF00023 | 0.403 |
DOC_CYCLIN_yCln2_LP_2 | 185 | 191 | PF00134 | 0.333 |
DOC_MAPK_gen_1 | 136 | 144 | PF00069 | 0.509 |
DOC_MAPK_MEF2A_6 | 143 | 152 | PF00069 | 0.480 |
DOC_PP2B_LxvP_1 | 183 | 186 | PF13499 | 0.326 |
DOC_PP2B_LxvP_1 | 25 | 28 | PF13499 | 0.486 |
DOC_PP4_FxxP_1 | 171 | 174 | PF00568 | 0.247 |
DOC_SPAK_OSR1_1 | 104 | 108 | PF12202 | 0.602 |
DOC_USP7_MATH_1 | 18 | 22 | PF00917 | 0.450 |
DOC_USP7_MATH_1 | 297 | 301 | PF00917 | 0.393 |
DOC_USP7_MATH_1 | 435 | 439 | PF00917 | 0.755 |
DOC_USP7_UBL2_3 | 139 | 143 | PF12436 | 0.577 |
DOC_USP7_UBL2_3 | 288 | 292 | PF12436 | 0.473 |
DOC_USP7_UBL2_3 | 295 | 299 | PF12436 | 0.523 |
DOC_WW_Pin1_4 | 131 | 136 | PF00397 | 0.644 |
DOC_WW_Pin1_4 | 14 | 19 | PF00397 | 0.438 |
DOC_WW_Pin1_4 | 339 | 344 | PF00397 | 0.326 |
LIG_14-3-3_CanoR_1 | 298 | 302 | PF00244 | 0.539 |
LIG_14-3-3_CanoR_1 | 304 | 314 | PF00244 | 0.526 |
LIG_14-3-3_CanoR_1 | 35 | 39 | PF00244 | 0.486 |
LIG_14-3-3_CanoR_1 | 4 | 12 | PF00244 | 0.396 |
LIG_14-3-3_CanoR_1 | 407 | 415 | PF00244 | 0.578 |
LIG_14-3-3_CanoR_1 | 42 | 46 | PF00244 | 0.419 |
LIG_Actin_WH2_2 | 372 | 390 | PF00022 | 0.561 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.415 |
LIG_BRCT_BRCA1_1 | 156 | 160 | PF00533 | 0.302 |
LIG_Clathr_ClatBox_1 | 213 | 217 | PF01394 | 0.423 |
LIG_FHA_1 | 231 | 237 | PF00498 | 0.294 |
LIG_GBD_Chelix_1 | 355 | 363 | PF00786 | 0.348 |
LIG_LIR_Gen_1 | 100 | 109 | PF02991 | 0.572 |
LIG_LIR_Gen_1 | 17 | 27 | PF02991 | 0.419 |
LIG_LIR_Gen_1 | 44 | 55 | PF02991 | 0.390 |
LIG_LIR_Nem_3 | 100 | 105 | PF02991 | 0.594 |
LIG_LIR_Nem_3 | 157 | 163 | PF02991 | 0.324 |
LIG_LIR_Nem_3 | 167 | 173 | PF02991 | 0.226 |
LIG_LIR_Nem_3 | 17 | 22 | PF02991 | 0.393 |
LIG_LIR_Nem_3 | 223 | 228 | PF02991 | 0.450 |
LIG_LIR_Nem_3 | 247 | 253 | PF02991 | 0.246 |
LIG_LIR_Nem_3 | 44 | 50 | PF02991 | 0.362 |
LIG_LIR_Nem_3 | 52 | 57 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 79 | 85 | PF02991 | 0.244 |
LIG_LYPXL_S_1 | 81 | 85 | PF13949 | 0.362 |
LIG_LYPXL_yS_3 | 82 | 85 | PF13949 | 0.362 |
LIG_NRBOX | 354 | 360 | PF00104 | 0.290 |
LIG_Pex14_1 | 149 | 153 | PF04695 | 0.315 |
LIG_Pex14_1 | 353 | 357 | PF04695 | 0.393 |
LIG_Pex14_2 | 319 | 323 | PF04695 | 0.290 |
LIG_REV1ctd_RIR_1 | 323 | 331 | PF16727 | 0.311 |
LIG_SH2_CRK | 108 | 112 | PF00017 | 0.556 |
LIG_SH2_CRK | 19 | 23 | PF00017 | 0.422 |
LIG_SH2_CRK | 329 | 333 | PF00017 | 0.440 |
LIG_SH2_NCK_1 | 189 | 193 | PF00017 | 0.333 |
LIG_SH2_STAP1 | 5 | 9 | PF00017 | 0.267 |
LIG_SH2_STAT3 | 162 | 165 | PF00017 | 0.302 |
LIG_SH2_STAT3 | 273 | 276 | PF00017 | 0.533 |
LIG_SH2_STAT5 | 154 | 157 | PF00017 | 0.300 |
LIG_SH2_STAT5 | 163 | 166 | PF00017 | 0.274 |
LIG_SH2_STAT5 | 206 | 209 | PF00017 | 0.292 |
LIG_SH2_STAT5 | 228 | 231 | PF00017 | 0.205 |
LIG_SH2_STAT5 | 253 | 256 | PF00017 | 0.296 |
LIG_SH2_STAT5 | 26 | 29 | PF00017 | 0.487 |
LIG_SH2_STAT5 | 305 | 308 | PF00017 | 0.497 |
LIG_SH2_STAT5 | 329 | 332 | PF00017 | 0.391 |
LIG_SH2_STAT5 | 96 | 99 | PF00017 | 0.550 |
LIG_SH3_3 | 185 | 191 | PF00018 | 0.239 |
LIG_SH3_3 | 77 | 83 | PF00018 | 0.362 |
LIG_Sin3_3 | 375 | 382 | PF02671 | 0.234 |
LIG_SUMO_SIM_anti_2 | 233 | 242 | PF11976 | 0.318 |
LIG_SUMO_SIM_anti_2 | 76 | 82 | PF11976 | 0.295 |
LIG_SUMO_SIM_par_1 | 233 | 242 | PF11976 | 0.320 |
LIG_SUMO_SIM_par_1 | 261 | 268 | PF11976 | 0.326 |
LIG_SUMO_SIM_par_1 | 375 | 380 | PF11976 | 0.467 |
LIG_TRAF2_1 | 191 | 194 | PF00917 | 0.324 |
LIG_TRAF2_1 | 417 | 420 | PF00917 | 0.760 |
LIG_TYR_ITIM | 80 | 85 | PF00017 | 0.415 |
LIG_UBA3_1 | 213 | 221 | PF00899 | 0.440 |
MOD_CDK_SPK_2 | 131 | 136 | PF00069 | 0.644 |
MOD_CDK_SPK_2 | 339 | 344 | PF00069 | 0.290 |
MOD_CDK_SPxxK_3 | 131 | 138 | PF00069 | 0.582 |
MOD_CDK_SPxxK_3 | 339 | 346 | PF00069 | 0.326 |
MOD_CK1_1 | 17 | 23 | PF00069 | 0.413 |
MOD_CK1_1 | 34 | 40 | PF00069 | 0.451 |
MOD_CK1_1 | 438 | 444 | PF00069 | 0.762 |
MOD_CK1_1 | 76 | 82 | PF00069 | 0.137 |
MOD_CK2_1 | 18 | 24 | PF00069 | 0.427 |
MOD_CK2_1 | 389 | 395 | PF00069 | 0.654 |
MOD_Cter_Amidation | 125 | 128 | PF01082 | 0.451 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.461 |
MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.614 |
MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.503 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.598 |
MOD_GSK3_1 | 14 | 21 | PF00069 | 0.440 |
MOD_GSK3_1 | 263 | 270 | PF00069 | 0.396 |
MOD_GSK3_1 | 335 | 342 | PF00069 | 0.329 |
MOD_GSK3_1 | 37 | 44 | PF00069 | 0.447 |
MOD_GSK3_1 | 395 | 402 | PF00069 | 0.684 |
MOD_GSK3_1 | 409 | 416 | PF00069 | 0.677 |
MOD_GSK3_1 | 427 | 434 | PF00069 | 0.745 |
MOD_GSK3_1 | 435 | 442 | PF00069 | 0.757 |
MOD_GSK3_1 | 443 | 450 | PF00069 | 0.769 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.410 |
MOD_LATS_1 | 405 | 411 | PF00433 | 0.662 |
MOD_N-GLC_1 | 31 | 36 | PF02516 | 0.648 |
MOD_N-GLC_1 | 427 | 432 | PF02516 | 0.365 |
MOD_N-GLC_1 | 447 | 452 | PF02516 | 0.542 |
MOD_N-GLC_2 | 313 | 315 | PF02516 | 0.393 |
MOD_NEK2_1 | 148 | 153 | PF00069 | 0.389 |
MOD_NEK2_1 | 265 | 270 | PF00069 | 0.315 |
MOD_NEK2_1 | 377 | 382 | PF00069 | 0.480 |
MOD_NEK2_1 | 409 | 414 | PF00069 | 0.690 |
MOD_NEK2_1 | 439 | 444 | PF00069 | 0.756 |
MOD_NEK2_1 | 73 | 78 | PF00069 | 0.305 |
MOD_NEK2_2 | 335 | 340 | PF00069 | 0.301 |
MOD_PIKK_1 | 447 | 453 | PF00454 | 0.755 |
MOD_PKA_1 | 452 | 458 | PF00069 | 0.774 |
MOD_PKA_2 | 297 | 303 | PF00069 | 0.535 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.394 |
MOD_PKA_2 | 34 | 40 | PF00069 | 0.504 |
MOD_PKA_2 | 41 | 47 | PF00069 | 0.449 |
MOD_PKA_2 | 452 | 458 | PF00069 | 0.774 |
MOD_Plk_1 | 177 | 183 | PF00069 | 0.333 |
MOD_Plk_1 | 73 | 79 | PF00069 | 0.332 |
MOD_Plk_2-3 | 389 | 395 | PF00069 | 0.601 |
MOD_Plk_4 | 148 | 154 | PF00069 | 0.346 |
MOD_Plk_4 | 209 | 215 | PF00069 | 0.331 |
MOD_Plk_4 | 232 | 238 | PF00069 | 0.373 |
MOD_Plk_4 | 297 | 303 | PF00069 | 0.496 |
MOD_Plk_4 | 73 | 79 | PF00069 | 0.347 |
MOD_ProDKin_1 | 131 | 137 | PF00069 | 0.639 |
MOD_ProDKin_1 | 14 | 20 | PF00069 | 0.442 |
MOD_ProDKin_1 | 339 | 345 | PF00069 | 0.326 |
MOD_SUMO_for_1 | 382 | 385 | PF00179 | 0.440 |
MOD_SUMO_rev_2 | 131 | 141 | PF00179 | 0.417 |
MOD_SUMO_rev_2 | 291 | 297 | PF00179 | 0.445 |
MOD_SUMO_rev_2 | 380 | 390 | PF00179 | 0.580 |
TRG_DiLeu_BaLyEn_6 | 404 | 409 | PF01217 | 0.506 |
TRG_ENDOCYTIC_2 | 108 | 111 | PF00928 | 0.504 |
TRG_ENDOCYTIC_2 | 19 | 22 | PF00928 | 0.396 |
TRG_ENDOCYTIC_2 | 253 | 256 | PF00928 | 0.290 |
TRG_ENDOCYTIC_2 | 369 | 372 | PF00928 | 0.368 |
TRG_ENDOCYTIC_2 | 82 | 85 | PF00928 | 0.417 |
TRG_ENDOCYTIC_2 | 86 | 89 | PF00928 | 0.402 |
TRG_Pf-PMV_PEXEL_1 | 407 | 411 | PF00026 | 0.463 |
TRG_Pf-PMV_PEXEL_1 | 95 | 100 | PF00026 | 0.381 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2N8 | Leptomonas seymouri | 63% | 100% |
A0A0S4JEY3 | Bodo saltans | 32% | 100% |
A0A0S4JIF9 | Bodo saltans | 35% | 100% |
A0A1X0NPU5 | Trypanosomatidae | 45% | 100% |
A0A1X0NPY1 | Trypanosomatidae | 45% | 100% |
A0A3S7X4J5 | Leishmania donovani | 88% | 100% |
A0A422MNN3 | Trypanosoma rangeli | 45% | 100% |
A4HJG0 | Leishmania braziliensis | 69% | 100% |
A4I6V5 | Leishmania infantum | 89% | 100% |
C9ZMC0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 100% |
C9ZWR6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
Q4Q684 | Leishmania major | 88% | 100% |
Q5E9R6 | Bos taurus | 29% | 100% |
Q9HA82 | Homo sapiens | 28% | 100% |